Financhill
Buy
57

ATR Quote, Financials, Valuation and Earnings

Last price:
$158.17
Seasonality move :
1.44%
Day range:
$154.26 - $156.18
52-week range:
$130.85 - $178.03
Dividend yield:
1.15%
P/E ratio:
28.46x
P/S ratio:
2.97x
P/B ratio:
4.06x
Volume:
260.5K
Avg. volume:
319.5K
1-year change:
5.56%
Market cap:
$10.3B
Revenue:
$3.6B
EPS (TTM):
$5.48

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ATR
AptarGroup
$898.6M $1.16 4.83% 18.91% $175.00
CATX
Perspective Therapeutics
$143.9K -$0.27 -- -55.87% $13.8214
DXR
Daxor
-- -- -- -- $23.50
POCI
Precision Optics
-- -- -- -- --
SMTI
Sanara MedTech
$23.5M -- 24.76% -- $49.00
WRBY
Warby Parker
$225.4M $0.11 12.86% -- $21.38
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ATR
AptarGroup
$155.94 $175.00 $10.3B 28.46x $0.45 1.15% 2.97x
CATX
Perspective Therapeutics
$2.3900 $13.8214 $177.4M -- $0.00 0% 16.84x
DXR
Daxor
$7.74 $23.50 $38.2M 25.61x $0.00 0% 17.73x
POCI
Precision Optics
$4.34 -- $33.2M -- $0.00 0% 1.57x
SMTI
Sanara MedTech
$30.39 $49.00 $270.1M -- $0.00 0% 2.83x
WRBY
Warby Parker
$19.81 $21.38 $2.4B -- $0.00 0% 3.03x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ATR
AptarGroup
28.4% 0.423 10.25% 0.73x
CATX
Perspective Therapeutics
-- -1.032 -- --
DXR
Daxor
2% 0.543 1.92% 0.09x
POCI
Precision Optics
13.24% 2.497 6.32% 1.19x
SMTI
Sanara MedTech
54.2% 0.992 15.79% 2.45x
WRBY
Warby Parker
-- 4.545 -- 2.17x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ATR
AptarGroup
$336.4M $115.5M 10.47% 14.97% 13.23% $23.4M
CATX
Perspective Therapeutics
-- -$21.8M -- -- -- -$26.2M
DXR
Daxor
-- -- 1.52% 1.57% -- --
POCI
Precision Optics
$418K -$2M -42.89% -53.48% -48.69% -$2M
SMTI
Sanara MedTech
$21.6M -$2.1M -17.44% -28.65% -9.43% -$3.7M
WRBY
Warby Parker
$126M $2.5M -4.25% -4.25% 1.1% $13.2M

AptarGroup vs. Competitors

  • Which has Higher Returns ATR or CATX?

    Perspective Therapeutics has a net margin of 8.88% compared to AptarGroup's net margin of --. AptarGroup's return on equity of 14.97% beat Perspective Therapeutics's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ATR
    AptarGroup
    37.91% $1.17 $3.6B
    CATX
    Perspective Therapeutics
    -- -$0.25 --
  • What do Analysts Say About ATR or CATX?

    AptarGroup has a consensus price target of $175.00, signalling upside risk potential of 12.22%. On the other hand Perspective Therapeutics has an analysts' consensus of $13.8214 which suggests that it could grow by 478.3%. Given that Perspective Therapeutics has higher upside potential than AptarGroup, analysts believe Perspective Therapeutics is more attractive than AptarGroup.

    Company Buy Ratings Hold Ratings Sell Ratings
    ATR
    AptarGroup
    4 2 0
    CATX
    Perspective Therapeutics
    10 1 0
  • Is ATR or CATX More Risky?

    AptarGroup has a beta of 0.580, which suggesting that the stock is 42.003% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.112, suggesting its more volatile than the S&P 500 by 11.175%.

  • Which is a Better Dividend Stock ATR or CATX?

    AptarGroup has a quarterly dividend of $0.45 per share corresponding to a yield of 1.15%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AptarGroup pays 30.45% of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend. AptarGroup's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ATR or CATX?

    AptarGroup quarterly revenues are $887.3M, which are larger than Perspective Therapeutics quarterly revenues of --. AptarGroup's net income of $78.8M is higher than Perspective Therapeutics's net income of -$18.2M. Notably, AptarGroup's price-to-earnings ratio is 28.46x while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AptarGroup is 2.97x versus 16.84x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ATR
    AptarGroup
    2.97x 28.46x $887.3M $78.8M
    CATX
    Perspective Therapeutics
    16.84x -- -- -$18.2M
  • Which has Higher Returns ATR or DXR?

    Daxor has a net margin of 8.88% compared to AptarGroup's net margin of --. AptarGroup's return on equity of 14.97% beat Daxor's return on equity of 1.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ATR
    AptarGroup
    37.91% $1.17 $3.6B
    DXR
    Daxor
    -- -- $36.5M
  • What do Analysts Say About ATR or DXR?

    AptarGroup has a consensus price target of $175.00, signalling upside risk potential of 12.22%. On the other hand Daxor has an analysts' consensus of $23.50 which suggests that it could grow by 203.62%. Given that Daxor has higher upside potential than AptarGroup, analysts believe Daxor is more attractive than AptarGroup.

    Company Buy Ratings Hold Ratings Sell Ratings
    ATR
    AptarGroup
    4 2 0
    DXR
    Daxor
    1 0 0
  • Is ATR or DXR More Risky?

    AptarGroup has a beta of 0.580, which suggesting that the stock is 42.003% less volatile than S&P 500. In comparison Daxor has a beta of -0.210, suggesting its less volatile than the S&P 500 by 120.981%.

  • Which is a Better Dividend Stock ATR or DXR?

    AptarGroup has a quarterly dividend of $0.45 per share corresponding to a yield of 1.15%. Daxor offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AptarGroup pays 30.45% of its earnings as a dividend. Daxor pays out -- of its earnings as a dividend. AptarGroup's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ATR or DXR?

    AptarGroup quarterly revenues are $887.3M, which are larger than Daxor quarterly revenues of --. AptarGroup's net income of $78.8M is higher than Daxor's net income of --. Notably, AptarGroup's price-to-earnings ratio is 28.46x while Daxor's PE ratio is 25.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AptarGroup is 2.97x versus 17.73x for Daxor. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ATR
    AptarGroup
    2.97x 28.46x $887.3M $78.8M
    DXR
    Daxor
    17.73x 25.61x -- --
  • Which has Higher Returns ATR or POCI?

    Precision Optics has a net margin of 8.88% compared to AptarGroup's net margin of -50.09%. AptarGroup's return on equity of 14.97% beat Precision Optics's return on equity of -53.48%.

    Company Gross Margin Earnings Per Share Invested Capital
    ATR
    AptarGroup
    37.91% $1.17 $3.6B
    POCI
    Precision Optics
    9.99% -$0.30 $15.2M
  • What do Analysts Say About ATR or POCI?

    AptarGroup has a consensus price target of $175.00, signalling upside risk potential of 12.22%. On the other hand Precision Optics has an analysts' consensus of -- which suggests that it could fall by --. Given that AptarGroup has higher upside potential than Precision Optics, analysts believe AptarGroup is more attractive than Precision Optics.

    Company Buy Ratings Hold Ratings Sell Ratings
    ATR
    AptarGroup
    4 2 0
    POCI
    Precision Optics
    0 0 0
  • Is ATR or POCI More Risky?

    AptarGroup has a beta of 0.580, which suggesting that the stock is 42.003% less volatile than S&P 500. In comparison Precision Optics has a beta of 0.233, suggesting its less volatile than the S&P 500 by 76.664%.

  • Which is a Better Dividend Stock ATR or POCI?

    AptarGroup has a quarterly dividend of $0.45 per share corresponding to a yield of 1.15%. Precision Optics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AptarGroup pays 30.45% of its earnings as a dividend. Precision Optics pays out -- of its earnings as a dividend. AptarGroup's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ATR or POCI?

    AptarGroup quarterly revenues are $887.3M, which are larger than Precision Optics quarterly revenues of $4.2M. AptarGroup's net income of $78.8M is higher than Precision Optics's net income of -$2.1M. Notably, AptarGroup's price-to-earnings ratio is 28.46x while Precision Optics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AptarGroup is 2.97x versus 1.57x for Precision Optics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ATR
    AptarGroup
    2.97x 28.46x $887.3M $78.8M
    POCI
    Precision Optics
    1.57x -- $4.2M -$2.1M
  • Which has Higher Returns ATR or SMTI?

    Sanara MedTech has a net margin of 8.88% compared to AptarGroup's net margin of -15.05%. AptarGroup's return on equity of 14.97% beat Sanara MedTech's return on equity of -28.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    ATR
    AptarGroup
    37.91% $1.17 $3.6B
    SMTI
    Sanara MedTech
    92.17% -$0.41 $80.1M
  • What do Analysts Say About ATR or SMTI?

    AptarGroup has a consensus price target of $175.00, signalling upside risk potential of 12.22%. On the other hand Sanara MedTech has an analysts' consensus of $49.00 which suggests that it could grow by 61.24%. Given that Sanara MedTech has higher upside potential than AptarGroup, analysts believe Sanara MedTech is more attractive than AptarGroup.

    Company Buy Ratings Hold Ratings Sell Ratings
    ATR
    AptarGroup
    4 2 0
    SMTI
    Sanara MedTech
    1 0 0
  • Is ATR or SMTI More Risky?

    AptarGroup has a beta of 0.580, which suggesting that the stock is 42.003% less volatile than S&P 500. In comparison Sanara MedTech has a beta of 1.383, suggesting its more volatile than the S&P 500 by 38.331%.

  • Which is a Better Dividend Stock ATR or SMTI?

    AptarGroup has a quarterly dividend of $0.45 per share corresponding to a yield of 1.15%. Sanara MedTech offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AptarGroup pays 30.45% of its earnings as a dividend. Sanara MedTech pays out -- of its earnings as a dividend. AptarGroup's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ATR or SMTI?

    AptarGroup quarterly revenues are $887.3M, which are larger than Sanara MedTech quarterly revenues of $23.4M. AptarGroup's net income of $78.8M is higher than Sanara MedTech's net income of -$3.5M. Notably, AptarGroup's price-to-earnings ratio is 28.46x while Sanara MedTech's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AptarGroup is 2.97x versus 2.83x for Sanara MedTech. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ATR
    AptarGroup
    2.97x 28.46x $887.3M $78.8M
    SMTI
    Sanara MedTech
    2.83x -- $23.4M -$3.5M
  • Which has Higher Returns ATR or WRBY?

    Warby Parker has a net margin of 8.88% compared to AptarGroup's net margin of 1.55%. AptarGroup's return on equity of 14.97% beat Warby Parker's return on equity of -4.25%.

    Company Gross Margin Earnings Per Share Invested Capital
    ATR
    AptarGroup
    37.91% $1.17 $3.6B
    WRBY
    Warby Parker
    56.3% $0.03 $354.1M
  • What do Analysts Say About ATR or WRBY?

    AptarGroup has a consensus price target of $175.00, signalling upside risk potential of 12.22%. On the other hand Warby Parker has an analysts' consensus of $21.38 which suggests that it could grow by 9.97%. Given that AptarGroup has higher upside potential than Warby Parker, analysts believe AptarGroup is more attractive than Warby Parker.

    Company Buy Ratings Hold Ratings Sell Ratings
    ATR
    AptarGroup
    4 2 0
    WRBY
    Warby Parker
    5 6 0
  • Is ATR or WRBY More Risky?

    AptarGroup has a beta of 0.580, which suggesting that the stock is 42.003% less volatile than S&P 500. In comparison Warby Parker has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ATR or WRBY?

    AptarGroup has a quarterly dividend of $0.45 per share corresponding to a yield of 1.15%. Warby Parker offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AptarGroup pays 30.45% of its earnings as a dividend. Warby Parker pays out -- of its earnings as a dividend. AptarGroup's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ATR or WRBY?

    AptarGroup quarterly revenues are $887.3M, which are larger than Warby Parker quarterly revenues of $223.8M. AptarGroup's net income of $78.8M is higher than Warby Parker's net income of $3.5M. Notably, AptarGroup's price-to-earnings ratio is 28.46x while Warby Parker's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AptarGroup is 2.97x versus 3.03x for Warby Parker. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ATR
    AptarGroup
    2.97x 28.46x $887.3M $78.8M
    WRBY
    Warby Parker
    3.03x -- $223.8M $3.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?

Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…

Where Will Coinbase Stock Be in 5 Years?
Where Will Coinbase Stock Be in 5 Years?

If you’ve been anywhere near the crypto world over the…

How High Will Planet Labs Stock Go in 2025?
How High Will Planet Labs Stock Go in 2025?

Today we dive into Planet Labs (NYSE: PL), the satellite…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
33
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
55
SBET alert for May 27

SharpLink Gaming [SBET] is up 454.46% over the past day.

Buy
60
MRUS alert for May 27

Merus NV [MRUS] is down 7.93% over the past day.

Buy
57
RGC alert for May 27

Regencell Bioscience Holdings [RGC] is down 9.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock